said Sanofi. In 2020, the company claimed a first by becoming the first to take an AI-designed drug into the human testing stage – a candidate for obsessive-compulsive disorder partnered with ...

Paul Hudson, CEO of the pharmaceutical firm Sanofi, has an argument for letting AI make top-level decisions in medicine: It has no attachments. Speaking at a panel in Davos on Tuesday, Hudson said ...

Sanofi has added another dimension to the use of artificial intelligence (AI) to seek out new drugs, partnering with BioMap on a project to find biologic therapies in a deal that could be worth up ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

[People] delegate AI to CDOs, and it's the biggest mistake you can make. At last year’s World Economic Forum gathering in Davos, Paul Hudson, CEO of French pharma giant Sanofi, made the case for AI ...